KLRS Kalaris Therapeutics Inc
Healthcare$5.21+5.89%ClosedMarket Cap: $97.4M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
3
Dispositions
1
Buy/Sell Ratio
3.00
Net Shares
+196,802
Shares Acquired
263,708
Shares Disposed
66,906
Total Bought ($)
$1.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri May 22 | AKKARAJU SRINIVAS | director, 10 percent owner: | Buy | 244,300 | $4.83 | 2,224,147 |
| Fri May 22 | AKKARAJU SRINIVAS | director, 10 percent owner: | Sell | 66,906 | $0.00 | 10,657,028 |
| Fri May 22 | AKKARAJU SRINIVAS | director, 10 percent owner: | Sell | 14,937 | $0.00 | 14,937 |
| Fri May 22 | AKKARAJU SRINIVAS | director, 10 percent owner: | Sell | 4,471 | $0.00 | 19,408 |
| Mon Mar 23 | Hagen Brett R | officer: Chief Accounting Officer | Sell | 1,915 | $6.72 | 0 |
| Mon Mar 23 | Hagen Brett R | officer: Chief Accounting Officer | Sell | 60,800 | $6.81 | 60,800 |
| Fri Mar 20 | Oxtoby Andrew | director, officer: See Remarks | Sell | 222,000 | $6.81 | 222,000 |
| Fri Mar 20 | Gall Matthew | officer: Chief Financial Officer | Sell | 95,000 | $6.81 | 95,000 |
| Fri Mar 20 | Feinsod Matthew | officer: Chief Medical Officer | Sell | 135,000 | $6.81 | 135,000 |
| Tue Feb 17 | AKKARAJU SRINIVAS | director, 10 percent owner: | Buy | 479,847 | $10.42 | 1,979,847 |
| Mon Dec 22 | AKKARAJU SRINIVAS | director, 10 percent owner: | Sell | 1,500,000 | $10.00 | 1,500,000 |
| Mon Nov 03 | Gall Matthew | officer: Chief Financial Officer | Sell | 235,000 | $4.99 | 235,000 |
| Mon Nov 03 | Gall Matthew | Sell | 0 | $0.00 | 0 | |
| Fri Apr 11 | Hagen Brett R | officer: Chief Accounting Officer | Sell | 50,262 | $7.31 | 50,262 |